Holen Sie sich die Stockscreener-App
1.87
1.35%
0.02
Schlusskurs vom Vortag:
$1.85
Offen:
$1.88
24-Stunden-Volumen:
194.40K
Relative Volume:
0.34
Marktkapitalisierung:
$27.30M
Einnahmen:
$709.00K
Nettoeinkommen (Verlust:
$-21.41M
KGV:
-1.9684
EPS:
-0.95
Netto-Cashflow:
$-19.70M
1W Leistung:
-9.86%
1M Leistung:
-10.29%
6M Leistung:
+57.56%
1J Leistung:
-90.08%
1-Tages-Spanne:
$1.81
$1.90
1-Wochen-Bereich:
$1.735
$2.08
52-Wochen-Spanne:
$0.7707
$23.90
Longeveron Inc Stock (LGVN) Company Profile
Firmenname
Longeveron Inc
Sektor
Branche
Telefon
305-302-7158
Adresse
1951 NW 7TH AVENUE, MIAMI
Vergleichen Sie LGVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| LGVN | 1.8703 | 27.30M | 709.00K | -21.41M | -19.70M | -0.95 |
| VRTX | 449.99 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.40 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 593.04 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.04 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.32 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Longeveron Inc Aktie (LGVN) Neueste Nachrichten
Longeveron stock opened 100% up on Wednesday: explore why - MSN
We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate - Yahoo Finance
ARMISTICE CAPITAL, LLC Acquires New Stake in Longeveron Inc - GuruFocus.com
The Escalator: Sanofi, Longeveron, Geron and more - MM+M Online
Earnings call: Longeveron Q3 2024 results show promise in regenerative medicine - Investing.com
Longeveron Inc. (NASDAQ:LGVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Longeveron reports Q3 EPS (34c), consensus (44c) - TipRanks
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
LGVNLongeveron Inc. Latest Stock News & Market Updates - StockTitan
A Look Ahead: Longeveron's Earnings Forecast - Benzinga
Longeveron names Devin Blass as new CTO - Investing.com
Longeveron names Devin Blass as new CTO By Investing.com - Investing.com UK
Longeveron Taps Devin Blass As CTO And SVP Of CMC - Contract Pharma
Longeveron Taps Devin Blass As CTO And SVP Of Chemistry, Manufacturing And Controls - Contract Pharma
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC) - The Manila Times
Longeveron Strengthens Leadership: Key Executive Hire Ahead of Critical BLA Submission | LGVN Stock News - StockTitan
Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2024 Result - Yahoo Finance
Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - StockTitan
Peeling Back The Layers: Exploring Longeveron Through Analyst Insights - Benzinga
Longeveron presents Alzheimer's therapy data at CTAD24 - Investing.com
Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times
Longeveron presents Alzheimer's therapy data at CTAD24 By Investing.com - Investing.com UK
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - StockTitan
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - ForexTV.com
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire Inc.
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Why has Longeveron stock tripled in two days? - MSN
Euro FX (E6N18) Quote - The Globe and Mail
S&P 500 Index (INX) QuotePress Release - The Globe and Mail
Scholastic Corp (SCHL-Q) QuotePress Release - The Globe and Mail
LGVN’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
LGVNRLongeveron Inc. Latest Stock News & Market Updates - StockTitan
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - ForexTV.com
Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected - GlobeNewswire
Renaissance Technologies LLC Invests $236,000 in Longeveron Inc. (NASDAQ:LGVN) - Defense World
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting - The Manila Times
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire
Longeveron to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - Marketscreener.com
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - The Manila Times
Longeveron to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Marketscreener.com
Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - The Manila Times
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa - MSN
Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa - The Manila Times
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa - StockTitan
Lamb Weston (LW) Scheduled to Post Quarterly Earnings on Tuesday - Defense World
Analysts review Longeveron Inc’s rating - Knox Daily
Lamb Weston (NYSE:LW) Price Target Raised to $75.00 - Defense World
Ratios Reveal: Breaking Down Longeveron Inc (LGVN)’s Financial Health - The Dwinnex
In the Green: Longboard Pharmaceuticals Inc (LBPH) Closes at 33.89, Up/Down 1.47 from Previous Day - The Dwinnex
Was there any good news for Longeveron Inc (LGVN) stock in the last session? - US Post News
Finanzdaten der Longeveron Inc-Aktie (LGVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Longeveron Inc-Aktie (LGVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hare Joshua | Chief Scientific Officer |
Apr 11 '24 |
Buy |
2.35 |
42,553 |
100,000 |
633,280 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer |
Apr 11 '24 |
Buy |
2.35 |
10,638 |
24,999 |
19,616 |
| Soffer Rock | Director |
Apr 10 '24 |
Buy |
2.35 |
106,383 |
250,000 |
176,619 |
| Soffer Rock | Director |
Apr 11 '24 |
Buy |
2.35 |
31,915 |
75,000 |
208,534 |
| Ross Cathy | Director |
Jan 10 '24 |
Buy |
1.31 |
5,000 |
6,544 |
10,000 |
| Baluch Khoso | Director |
Dec 29 '23 |
Buy |
1.43 |
8,322 |
11,915 |
15,000 |
| Baluch Khoso | Director |
Dec 28 '23 |
Buy |
1.40 |
1,678 |
2,342 |
6,678 |
| PFEFFER JEFFREY | Director |
Dec 28 '23 |
Buy |
1.35 |
10,000 |
13,500 |
15,000 |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):